Abstract
IntroductionSystemic sclerosis (SSc) is a rare, autoimmune disease with possible life-threatening internal organ involvement. Because of its rarity and heterogeneous clinical presentation, studies on this disease may be difficult to carry out. OBJECTIVES We sought to describe patients at first hospitalization for SSc in Poland from 2013 to 2019. The study measured SSc incidence trend, comorbidities, factors related to this disease among hospitalized patients in Poland.Material and methodsWe conducted a retrospective, population-based study using hospital discharge records compiled by the National Institute of Public Health.ResultsThe study group covered 4,633 patients hospitalized with SSc diagnosis for the first time in 2013-2019. The mean and median age were 53.9 (95% CI: 53.4 – 54.3, SD: 16.6) and 57 years (IQR: 44 - 66). In the study group, female patients accounted for 81.3% of all patients, and they were significantly older than male patients (54.6 vs 50.4 years; P<0.001). The crude incidence was estimated at 1.72 per 100 000 person-years (95% CI 1.67-1.77). The SSc incidence rate was significantly higher in urban than rural areas of Poland (1.83 vs 1.46 per 100,000; P<0.001). In patients with progressive systemic sclerosis in comparison to other forms of SSc we observed a significantly rare presence of selected groups of diseases.ConclusionsPresented data on SSc in Poland may also be helpful in comparative analyses in the European context. Territorial factors may have a significant impact on the occurrence of SSc in Poland.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.